MOGGI PIGNONE, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.527
EU - Europa 7.419
AS - Asia 5.623
SA - Sud America 783
AF - Africa 194
OC - Oceania 126
Continente sconosciuto - Info sul continente non disponibili 1
Totale 26.673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.401
RU - Federazione Russa 3.302
SG - Singapore 1.795
CN - Cina 1.346
HK - Hong Kong 1.005
PL - Polonia 824
IT - Italia 805
IE - Irlanda 736
BR - Brasile 639
KR - Corea 596
SE - Svezia 558
DE - Germania 325
FI - Finlandia 253
VN - Vietnam 251
IN - India 174
UA - Ucraina 169
GB - Regno Unito 157
AU - Australia 121
FR - Francia 115
TR - Turchia 97
JO - Giordania 91
CA - Canada 74
ID - Indonesia 61
AR - Argentina 55
CI - Costa d'Avorio 43
BD - Bangladesh 41
ES - Italia 32
JP - Giappone 31
ZA - Sudafrica 31
IQ - Iraq 30
EC - Ecuador 29
MX - Messico 28
NL - Olanda 28
CH - Svizzera 23
MA - Marocco 23
BJ - Benin 19
AT - Austria 16
CO - Colombia 15
EG - Egitto 14
BE - Belgio 13
PY - Paraguay 13
VE - Venezuela 13
KE - Kenya 12
TN - Tunisia 12
TH - Thailandia 11
PK - Pakistan 10
SA - Arabia Saudita 9
LT - Lituania 8
UZ - Uzbekistan 8
AL - Albania 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
HU - Ungheria 6
KZ - Kazakistan 6
NP - Nepal 6
SD - Sudan 6
AZ - Azerbaigian 5
CL - Cile 5
CM - Camerun 5
CZ - Repubblica Ceca 5
IL - Israele 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
SC - Seychelles 5
UY - Uruguay 5
JM - Giamaica 4
KG - Kirghizistan 4
MY - Malesia 4
PA - Panama 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
BG - Bulgaria 3
BH - Bahrain 3
BW - Botswana 3
BY - Bielorussia 3
CR - Costa Rica 3
ET - Etiopia 3
HR - Croazia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BO - Bolivia 2
CY - Cipro 2
GE - Georgia 2
HN - Honduras 2
KH - Cambogia 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
ML - Mali 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AO - Angola 1
BB - Barbados 1
Totale 26.650
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.707
Ashburn 1.247
Singapore 1.209
Fairfield 1.112
Hong Kong 832
Warsaw 821
Chandler 803
Dublin 728
Seoul 593
Woodbridge 491
Seattle 444
Cambridge 438
Beijing 375
Wilmington 369
Houston 362
Hefei 307
San Jose 287
Jacksonville 268
Florence 235
Buffalo 210
Princeton 196
Los Angeles 190
Ann Arbor 181
Altamura 164
Lawrence 164
Moscow 148
Boston 131
Munich 129
Boardman 122
Dallas 117
Melbourne 117
Medford 113
The Dalles 111
Ho Chi Minh City 91
Mumbai 88
Paris 76
San Diego 75
São Paulo 72
New York 71
Izmir 67
Shanghai 63
Kent 62
Helsinki 57
Turku 44
Abidjan 43
Hanoi 43
Milan 43
Falls Church 40
Jakarta 39
Dong Ket 37
Redondo Beach 35
Yubileyny 34
Norwalk 33
Toronto 32
Chicago 29
Tokyo 27
Pune 25
Rome 23
Guangzhou 21
London 21
Andover 20
Hillsboro 20
Clifton 19
Cotonou 19
Frankfurt am Main 19
Johannesburg 18
Montreal 17
Belo Horizonte 16
Brooklyn 16
Denver 16
Poplar 16
Bern 15
Bengaluru 13
Brussels 13
Phoenix 13
Turin 13
Baghdad 12
Chennai 12
Curitiba 12
Guayaquil 12
Stockholm 12
West Jordan 12
Dearborn 11
Manchester 11
Naples 11
Salt Lake City 11
Vienna 11
Orem 10
San Francisco 10
Shenzhen 10
Ankara 9
Atlanta 9
Barcelona 9
Bremen 9
Cape Town 9
Mexico City 9
Rio de Janeiro 9
Shijiazhuang 9
Amman 8
Council Bluffs 8
Totale 17.520
Salva come PNG Salva come JPEG
Nome #
[Peripheral nervous system in limited systemic sclerosis]. 311
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 305
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 298
Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. 233
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 224
Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit 224
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 218
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 211
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 206
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 195
A rare case of Candida glabrata spondylodiscitis: case report and literature review 186
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. 183
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 183
The platypnea-orthodeoxia syndrome: an unusual case of dyspnea 182
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 182
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 181
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 180
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 180
Acute heart failure in the elderly: setting related differences in clinical features and management 176
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 175
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 174
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 174
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 174
Dimensions of psychological dysfunction in patients with fibromyalgia: development of an Italian questionnaire. 170
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 169
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 169
Letter to Habets JGV et al. on “A rare case of Candida glabrata spondylodiscitis: case report and literature review” 168
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 168
Oxidative stress in Systemic Sclerosis. 166
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 163
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 162
Systemic amyloidosis: a challenge for the rheumatologist. 161
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 161
Therapeutic challenges for systemic sclerosis: facts and future targets. 160
Amyloidoses 158
The safety of iloprost in systemic sclerosis in a real-life experience 158
Accuracy of lung ultrasound performed with handheld ultrasound device in internal medicine: an observational study 156
Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. 156
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 156
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 153
HFmrEF in elderly patients hospitalised for acute heart failure: data from the ATHENA registry 153
Methodological models for in vitro amplification and maintenance of human articular chondrocytes from elderly patients 152
Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism 152
Dural metastasis without subdural hematoma or subdural fluid collection in a patient with signet ring cell gastric adenocarcinoma 151
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 151
Valutazione circadiana dell’ attività fibrinolitica circolante nella Sclerosi Sistemica. 151
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 151
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 150
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 149
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 149
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 149
Therapeutic challenges for systemic sclerosis: facts and future targets. 149
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 148
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 147
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 145
The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine 144
The doctor who stared at schistocytes: an intriguing case of suspected thrombotic microangiopathic anemia 144
EULAR EVIDENCE BASED RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGMENT OF GOUT 143
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 142
Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists 141
Current Treatment Options in Raynaud's Phenomenon. 139
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 139
A case of persistent hiccup after laparoscopic cholecystectomy. 139
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 138
Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. 136
Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment. 135
Angiotensin converting enzyme a new tool for the follow-up of endothelial injury in paediatric vasculitides. 135
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 135
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 134
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. 134
HFmrEF in elderly patients: the pathogenetic role of ischemia. Real world data from the ATHENA registry 134
Central nervous system hemangiopericytoma with bone and lung metastases: a case report. 133
Acute heart failure in the real world: are elderly patients managed in accordance to current guidelines? Data from the ATHENA registry 133
ANGIOTENSIN CONVERTING ENZYME A NEW TOOL FOR THE FOLLOW-UPOF ENDOTHELIAL INJURY IN PEDIATRIC VASCULITIDES 133
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 133
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 133
Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis 132
HFrEF, HFmrEF and HFpEF: which is the treatment of choice at discharge? Real world data from the ATHENA registry 132
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 132
Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease. 131
[Patterns of ventricular late potentials in systemic sclerosis: a noninvasive method in the study of cardiac involvement]. 131
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 131
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 131
Cardiac amyloidosis: the heart of the matter. 130
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach. 129
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 129
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 129
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) 127
Tako-Tsubo like syndrome in systemic sclerosis: a sign of myocardial Raynaud Phenomenon? 127
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 127
Mycosis fungoides: from early stages to fatal central nervous system involvement 126
Sarcoidosis 125
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. 124
Acute heart failure in the elderly: which are the main precipitating causes of heart failure? Real world evidence from the ATHENA registry 124
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 124
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 124
"Autoimmunity part D; Autoimmune disease, annus mirabilis" - Chapter: Exercise doppler echo cardiography identifies reclini asympthomatic pulmonary hypertension in sistemi sclerosis. 123
Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc? 123
Oral lactobacillus species in systemic sclerosis 123
Acute heart failure in the elderly: real world evidence from the ATHENA registry 122
Totale 15.689
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021804 0 0 0 0 0 0 76 129 155 209 113 122
2021/20221.269 51 107 53 68 66 116 46 69 62 64 194 373
2022/20233.119 339 544 118 266 249 584 399 158 295 24 88 55
2023/20241.345 67 139 205 59 87 207 72 244 25 90 96 54
2024/20258.820 301 882 557 1.463 2.467 1.014 271 425 485 266 340 349
2025/20266.506 1.217 1.430 908 751 1.240 439 521 0 0 0 0 0
Totale 26.879